Ye Xu
机构:Central South University of Forestry and Technology, Shanghai Medical College of Fudan University, Central South University, Sun Yat-sen University, Chongqing University, Sichuan University, Fudan University, Chinese PLA General Hospital, Chengdu University of Technology, Quzhou City People's Hospital, West China Hospital of Sichuan University, Second Affiliated Hospital of Guangzhou Medical University, Fudan University Shanghai Cancer Center, Hunan Cancer Hospital, Quzhou University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Zhejiang Provincial People's Hospital, Shanghai Institute of Hematology, Shanghai Clinical Research Center, Children's Hospital of Chongqing Medical University, Huashan Hospital, Chinese People's Liberation Army, Chongqing Medical University, Guangzhou Medical University · ORCID:0000-0003-0455-4556
发表论文 275 篇 · 总被引 8579 次 · h-index 48
代表论文
- Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation (2025 · Signal Transduction and Targeted Therapy · 被引 20)
- Large Language Model in Materials Science: Roles, Challenges, and Strategic Outlook (2025 · Advanced Intelligent Discovery · 被引 8)
- Closing the loop in next-generation sensing through shadow sphere lithography, plasmonics, and artificial intelligence (2025 · Chemical Society Reviews · 被引 7)
- Born–Kuhn‐Driven 2.5D Chiral Metamaterials (2025 · Advanced Optical Materials · 被引 4)
- Alisertib impairs the stemness of hepatocellular carcinoma by inhibiting purine synthesis (2025 · Journal of Biological Chemistry · 被引 3)
- A Large‐Scale Retrospective Study of Serum Des‐Gamma‐Carboxy Prothrombin as a Diagnostic Marker of HCC : Effect of Liver Function on Specificity (2025 · Journal of Clinical Laboratory Analysis · 被引 3)